Fortimedix develops and manufactures precision articulating surgical instruments that provide multi-degree freedom control for minimally invasive procedures. The platform offers rapid prototyping, regulatory‑ready design, and scalable production, enabling device OEMs and hospitals to bring advanced, articulated tools to market quickly.
Funding
Funding not disclosed
Founders
Product
Problem
Surgeons and medical device manufacturers often lack access to highly articulated, minimally invasive instruments that combine precision control with reliable manufacturing, limiting the ability to perform complex procedures through small incisions.
Solution
Fortimedix, now operating as Medtronic Articulating Technologies, bridges this gap by developing and manufacturing advanced articulating surgical instruments. Leveraging high‑tech device engineering and Medtronic’s manufacturing expertise, the team creates devices that enable precise navigation and manipulation in confined anatomical spaces. Their platform supports rapid prototyping, regulatory‑ready design, and scalable production, allowing partners to bring disruptive minimally invasive solutions to market faster. By integrating these instruments with existing Medtronic product families, they enhance the overall therapeutic ecosystem for a wide range of specialties.
Target Audience
Primary customers are medical device OEMs and surgical equipment manufacturers seeking to add articulating capabilities to their product lines, as well as hospitals and surgical centers adopting advanced minimally invasive technologies.
Features
- Precision articulating mechanisms that provide multi‑degree freedom control at the instrument tip
- Robust, sterilizable designs compatible with standard minimally invasive surgical ports
- Rapid prototyping and iterative design cycles using advanced CAD and additive manufacturing
- Full regulatory compliance support (ISO, CE, FDA) to accelerate market entry
- Scalable, best‑in‑class manufacturing processes ensuring consistent quality at volume
- Integration capability with Medtronic’s broader device portfolio and digital platforms